Cadila Covid Vaccine
-
{
- All
- News
- Videos
- Web Stories
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
South Korea's Enzychem To Make Cadila's COVID-19 Shot
South Korea's Enzychem Lifesciences would make at least 80 million doses of India's homegrown DNA COVID-19 vaccine from Cadila Healthcare, the Indian drugmaker said on Wednesday.
-
Zydus To Produce 1 Crore Doses Per Month By October, Says Chief
Zydus Cadila, whose Covid vaccine ZyCoV-D for adults and children aged 12 years and above got approval yesterday, said it hopes to produce one crore doses per month by October.
-
Drug Regulator Examining Zydus Cadila's Covid Vaccine For Children: Dr VK Paul
Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
-
Zydus Cadila Gets Nod For Phase 3 Trials Of Its Covid Vaccine Candidate
The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country's first DNA vaccine candidate against COVID-19 being developed by Zydus Cadila, the Department of Biotechnology said on Sunday.
-
Zydus Cadila Covid Therapy "PegiHep" Gets Nod For Phase 3 Clinical Trial
Drug firm Zydus Cadila said today that it has received the approval from the Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 patients.
-
Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially
Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.
-
South Korea's Enzychem To Make Cadila's COVID-19 Shot
South Korea's Enzychem Lifesciences would make at least 80 million doses of India's homegrown DNA COVID-19 vaccine from Cadila Healthcare, the Indian drugmaker said on Wednesday.
-
Zydus To Produce 1 Crore Doses Per Month By October, Says Chief
Zydus Cadila, whose Covid vaccine ZyCoV-D for adults and children aged 12 years and above got approval yesterday, said it hopes to produce one crore doses per month by October.
-
Drug Regulator Examining Zydus Cadila's Covid Vaccine For Children: Dr VK Paul
Drugs Controller General of India (DCGI) is examining pharmaceutical major Zydus Cadila's COVID-19 vaccine for children, said Dr VK Paul, Member-Health, Niti Aayog on Friday.
-
Zydus Cadila Gets Nod For Phase 3 Trials Of Its Covid Vaccine Candidate
The Drugs Controller General of India (DCGI) has approved conducting phase III trials of the country's first DNA vaccine candidate against COVID-19 being developed by Zydus Cadila, the Department of Biotechnology said on Sunday.
-
Zydus Cadila Covid Therapy "PegiHep" Gets Nod For Phase 3 Clinical Trial
Drug firm Zydus Cadila said today that it has received the approval from the Drugs Controller General of India (DCGI) to start phase 3 clinical trials with its biological therapy PegiHep in COVID-19 patients.
